Intellia Thera CS (NTLA)

$22.93 0.41 (1.82%)
16:00 EDT NTLA Stock Quote Delayed 30 Minutes

3 Gene Editing Stocks with Potential to Transform Medicine

Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks.

NTLA Stock Earnings: Intellia Therapeutics Misses EPS, Misses Revenue for Q2 2024

The 3 Best Cathie Wood Stocks to Buy in August 2024

7 Biotech Stocks to Keep on Your Clinical Radar

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 2.02B
PE Ratio -4.18
EPS -5.48
Volume (Avg. Vol.) 1.38M
Day's Range $22.86 - $23.68
52-Week Range $19.21 - $34.94
Dividend & Yield N/A (N/A)